Profile: Nanoro health and demographic surveillance system

International Journal of Epidemiology

Volumn 41, Issue 5, 2012, Pages 1293-1301

  Derra, Karim ^a   Rouamba, Eli ^a   Kazienga, Adama ^a   Ouedraogo, Sayouba ^a   Tahita, Marc C ^a,b   Sorgho, Hermann ^a,b   Valea, Innocent ^a,c   Tinto, Halidou ^a,b,c  

^a Clinical Research Unit of Nanoro (CRUN)   (Burkina Faso)

^b Institut de Recherche en Sciences de la Santé   (Burkina Faso)

^c CENTRE MURAZ   (Burkina Faso)

Author keywords

Burkina Faso; Clinical trial; Demography; Epidemiology; Fertility; INDEPTH network; Migration; Morbidity; Mortality; Nanoro; Population dynamics

Indexed keywords

DEMOGRAPHIC SURVEY; EPIDEMIOLOGY; HEALTH RISK; MIGRATORY POPULATION; MORBIDITY; MORTALITY; PREGNANCY; PUBLIC HEALTH; SPATIOTEMPORAL ANALYSIS;

ARTICLE; BIRTH; BURKINA FASO; CLINICAL TRIAL (TOPIC); CULTURAL FACTOR; DEMOGRAPHY; HEALTH CARE SYSTEM; HUMAN; MEDICAL INFORMATION; MEDICAL INFORMATION SYSTEM; MIGRATION; MORTALITY; NANORO HEALTH AND DEMOGRAPHIC SURVEILLANCE SYSTEM; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BURKINA FASO; CHILD; CHILD, PRESCHOOL; CULTURE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POPULATION DYNAMICS; RESIDENCE CHARACTERISTICS; SENTINEL SURVEILLANCE; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; VITAL STATISTICS; YOUNG ADULT;

BURKINA FASO;

EID: 84867583840     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys159     Document Type: Article

References (13)

1. Group TFA-BC (4ABC) S. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Medicine 2011;8:e1001119.
2. Kattenberg JH, Tahita CM, Versteeg IA et al. Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy. Trop Med Int Health 2012; 17:550-57.
3. Bassat Q, Mulenga M, Tinto H et al. Dihydroartemisininpiperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PloS One Med 2009;4:e7871.
4. Partnership SCT. First results of phase 3 trial of RTS, S/ AS01 malaria vaccine in African children. N Engl J Med 2011;365:1863-75.
5. Organisation Mondiale de la Santé (OMS). Normes D'autopsie Verbale: Etablissement Et Attribution De La Cause De Déce's. Geneva, 2009, p. 131; Volume 1 ISBN 978 94 4 254721 4 (NLM classification: WA 900).
6. Yé M, Diboulo E, Niamba L et al. An improved method for physician-certified verbal autopsy reduces the rate of discrepancy: experiences in the Nouna Health and Demographic Surveillance Site (NHDSS), Burkina Faso. Popul Health Metr 2011;9:34.
7. Joshi R, Lopez AD, Macmahon S, Reddy S, Dandona R, Neal B. Verbal autopsy coding: are multiple coders better than one? World Health 2009;87:51-57.
8. Oti SO, Kyobutungi C. Verbal autopsy interpretation: a comparative analysis of the InterVA model versus physician review in determining causes of death in the Nairobi DSS. Popul Health Metr 2010;8:21.
9. Sié A, Louis VR, Gbangou A et al. The health and demographic surveillance system (HDSS) in Nouna, Burkina Faso, 1993-2007. Glob Health Action 2010;3:1-10.
10. Phillips J, MacLeod B, Pence B. The household registration system 2 (HRS2) user's manual, version 3.0. Demogr Res 2000;2; doi:10.4054/DemRes.2000.2.6.
11. Fottrell E, Kahn K, Tollman S, Byass P. Probabilistic methods for verbal autopsy interpretation: interVA robustness in relation to variations in a priori probabilities. PLoS ONE 2011;6:1-7.
12. Byass P, Fottrell E, Huong DL et al. Refining a probabilistic model for interpreting verbal autopsy data. Trop Med Int Health 2010;34:26-31.
13. Bauni E, Ndila C, Mochamah G et al. Validating physician-certified verbal autopsy and probabilistic modeling (InterVA) approaches to verbal autopsy interpretation using hospital causes of adult deaths. Popul Health Metr 2011;9:49.